Cilgavimab and Tixagevimab As Pre-Exposure Prophylaxis in Vaccine Non-Responder Kidney Transplant Recipients During a Period of Prevalent SARS-CoV-2 BA.2 and BA.4/5 Variants—a Prospective Cohort Study (RESCUE-TX)
EBIOMEDICINE（2024）
Key words
COVID-19,Kidney transplant,Vaccine non-responder,Cilgavimab/tixagevimab
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined